Dear Partners,

Necessitated by the unprecedented situation created by Covid-19, several industry events and tradeshows across the world have been postponed or stand cancelled. While we were looking forward to meet you, we at Piramal Pharma Solutions have had to take several precautionary measures to protect both our employees and customers, worldwide.

As we move forward in these extraordinary times, we want to assure you that that we are operational by taking the right safety measures and abundant precautions to ensure that we continue to support you and your patients.

While all of us are working remotely for now, you can schedule a discussion with us and we would be glad to help ensure you meet your pharmaceutical development and supply needs and thereby, your clinical and commercial timelines.

Please feel free to reach out to us at:

Our best wishes to colleagues, friends and family.

Best Regards,
Piramal Pharma Solutions

PiramalPharma Solutions Logo

Debashish Chakravorty  LinkedIn

Executive Vice President, India and UK Formulations

Debashish Chakravorty is the Executive Vice President for India and UK formulations at Piramal Pharma Solutions (PPS). Mr.Chakravorty is responsible for various sites including Pithampur, Madhya Pradesh, an Oral Solid Dosage (OSD) + Form Fill and Seal (FFS) for Global Market, Mahad, Maharashtra, an OSD and Vitamins for RoW & Development activities for PPDS and Ahmedabad, Gujarat for OSD Development for Global Market, along with Morpeth, an OSD & API site in Newcastle, UK. He has techno-commercial understanding of operations and has been responsible for P&L for the sites over the years.

He works with customers to drive seamless integration of operations from early stage through to life cycle management and is responsible for financial growth.

Mr. Chakravorty has been associated with Piramal for over three decades in various roles. Before his current assignment, he held a site lead position for Pithampur (PTP) for 7 years. Has also led the Global Business and Strategic Projects for PPS encompassing multiple geographies and cultures.

He is a Manufacturing Pharmacist (OSD background) and holds an MBA in Finance.

Leadership Team

Peter DeYoung    LinkedIn

CEO, Piramal Global Pharma

Stuart Needleman    LinkedIn

Chief Commercial Officer &
Chief Patient Centricity Officer, Piramal Pharma Solutions

Herve Berdou    LinkedIn

Chief Operating Officer, Piramal Pharma Solutions

Paolo Fiorino    LinkedIn

Executive Vice President,
North America API and Formulations, Piramal Pharma Solutions

Robert Munday    LinkedIn

Executive Vice President,
Aeseptic and Biologics, Piramal Pharma Solutions

Surinder Gulati    LinkedIn

Executive Vice President,
India API and Operations, Piramal Pharma Solutions

Rashida Najmi    LinkedIn

Chief Quality Officer, Piramal Pharma Solutions

Christopher Leahy    LinkedIn

Senior Vice President,
Finance, Piramal Pharma Solutions